Showing results (31-40 of 48) with videos related to
Sort By:
Pageof 5
Scientific Reports|May 19, 2022
Tyrosine O-sulfation proteoforms affect HIV-1 monoclonal antibody potencyCindy X Cai, Nicole A Doria-Rose, Nicole A Schneck, et al.Journal of Translational Medicine|January 10, 2024
Targeting the SphK1/S1P/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesisXin Tracy Liu, Yu Huang, Da Liu, et al.Science (New York, N.Y.)|March 24, 2022
Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529Tongqing Zhou, Lingshu Wang, John Misasi, et al.Vaccines|April 3, 2021
Design of Alphavirus Virus-Like Particles Presenting Circumsporozoite Junctional Epitopes That Elicit Protection against MalariaJoseph R Francica, Wei Shi, Gwo-Yu Chuang, et al.Nature Communications|November 21, 2023
Antibody-directed evolution reveals a mechanism for enhanced neutralization at the HIV-1 fusion peptide siteBailey B Banach, Sergei Pletnev, Adam S Olia, et al.Cell Reports|May 31, 2024
Cholesterol reduction by immunization with a PCSK9 mimicBaoshan Zhang, Gwo-Yu Chuang, Andrea Biju, et al.Mabs|February 2, 2023
Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potencyBaoshan Zhang, Jason Gorman, Young D Kwon, et al.The Journal of Experimental Medicine|June 23, 2022
Highly protective antimalarial antibodies via precision library generation and yeast display screeningBailey B Banach, Prabhanshu Tripathi, Lais Da Silva Pereira, et al.Iscience|July 18, 2025
In silico improvement of affinity for highly protective anti-malarial antibodiesMateo Reveiz, Prabhanshu Tripathi, Lais Da Silva Pereira, et al.Cell|June 9, 2023
Vaccine elicitation and structural basis for antibody protection against alphavirusesMatthew S Sutton, Sergei Pletnev, Victoria Callahan, et al.Pageof 5